Search Results 121-130 of 9941 for Terminal
... terminal pro b-type natriuretic peptide (NT-proBNP). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
Our patients confirm the observation that C-terminal FGF23 can be normal but may be inappropriately so for the extent of hypophosphatemia; however, intact FGF23 ...
The primary objective is to evaluate whether macitentan 10 mg reduces N-terminal pro-brain natriuretic peptide (NT-pro-BNP) as compared to placebo in these ...
Subject has a terminal illness. For female subjects, subject is currently known to be pregnant or lactating. Subject has any other acute or chronic ...
It is our hypothesis that blockade of terminal complement activation with eculizumab at the time of transplant in combination with our current protocols ...
This rare disease causes an early decay of nerve cells in the brain. Learn about its symptoms and how treatments may help.
Terminalfour Search is used to output search results from college.mayo.edu or some subsection. How to use. Add a Terminalfour Search content type in a ...
Learn about the diagnosis and treatment for this type of glioma brain tumor. Treatments include surgery, chemotherapy and radiation therapy.
Mental dependence (addiction) is not likely to occur when narcotics are used for this purpose. Physical dependence may lead to withdrawal side effects if ...
This motor neuron disease causes nerves within the brain to slowly break down. It causes muscle weakness primarily in the legs, arms and tongue.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.